SCHEMBL4551612

SCHEMBL4551612

Cc1ncc(NC(=O)c2cc(N3CCOCC3)cc(C(F)(F)F)c2)cc1C(=O)Nc1ccc(NCC2CCOCC2)nc1

nearest known ligand 0.52

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 18/20 0.52
BRAF P15056 16/20 0.52
CSF1R P07333 1/20 0.49
MAPK14 Q16539 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4417256 0.98 RAF1 (0.52) RAF1BRAFCSF1RMAPK14
SCHEMBL4409370 0.96 RAF1 (0.51) RAF1BRAFCSF1RMAPK14
SCHEMBL5487361 0.90 MAPK14 (0.47) RAF1BRAFMAPK14
SCHEMBL5484352 0.90 CSF1R (0.50) RAF1BRAFCSF1RMAPK14
SCHEMBL5490015 0.90 RAF1 (0.52) RAF1BRAFCSF1R
SCHEMBL4411276 0.89 RAF1 (0.53) RAF1BRAFCSF1R
SCHEMBL4408418 0.88 CRHR1 (0.48) RAF1BRAFMAPK14
SCHEMBL5490935 0.87 CRHR1 (0.45) RAF1BRAFMAPK14
SCHEMBL4551651 0.86 CRHR1 (0.45) RAF1BRAFMAPK14
SCHEMBL14534670 0.86 MAPK14 (0.46) RAF1BRAFMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035005-A2 THERAPY USING CYTOKINE INHIBITORS Kemia, INC. (US) 2009-03-18 EP disclosed
WO-2007146712-A2 THERAPY USING CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-12-21 WO disclosed
WO-2007056016-A2 BISAMIDE CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-05-18 WO disclosed